Human Parathyroid Hormone Liquid
NDC Package 68594-002-99

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Human Parathyroid Hormone liquids is a medication a man-made form of parathyroid hormone, a natural substance made in your body by the parathyroid glands. This formulation utilizes a liquid delivery system. Marketed by Boehringer Ingelheim Rcv Gmbh & Co Kg, this product is identified by NDC 68594-002.

Identification & Billing

NDC Package Code
68594-002-99
Package Description
3.5 kg in 1 DRUM
Product Code
11-Digit Billing Format
68594000299

Clinical Specifications

Proprietary Name
Human Parathyroid Hormone
Non-Proprietary Name
Human Parathyroid Hormone
Substance Name
Parathyroid Hormone
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s)
Usage Information
This medication is a man-made form of parathyroid hormone, a natural substance made in your body by the parathyroid glands. Parathyroid hormone helps to regulate and maintain the balance of calcium and phosphorus in your body. This medication is used along with calcium and vitamin D to help control low blood calcium due to low levels of parathyroid hormone.

Regulatory & Marketing

Labeler Name
Boehringer Ingelheim Rcv Gmbh & Co Kg
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
10-31-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68594-002-99 identifies a specific commercial package of 3.5 kg in 1 drum of Human Parathyroid Hormone (UNFINISHED drug), a bulk ingredient labeled by Boehringer Ingelheim Rcv Gmbh & Co Kg. This liquid is formulated for use and contains parathyroid hormone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Boehringer Ingelheim Rcv Gmbh & Co Kg on October 31, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is a man-made form of parathyroid hormone, a natural substance made in your body by the parathyroid glands. Parathyroid hormone helps to regulate and maintain the balance of calcium and phosphorus in your body. This medication is used along with calcium and vitamin D to help control low blood calcium due to low levels of parathyroid hormone.

How is this Boehringer Ingelheim Rcv Gmbh & Co Kg product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68594000299. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68594-002-99
11-Digit CMS (5-4-2)
68594-0002-99

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.